Neurocognitive screening following acquired brain injury: an adaptation of the Birmingham Cognitive Screen for Zimbabwe (Zim-BCoS)
| dc.contributor.advisor | Njomboro, Progress | |
| dc.contributor.author | Machando, Debra | |
| dc.date.accessioned | 2021-02-04T09:14:20Z | |
| dc.date.available | 2021-02-04T09:14:20Z | |
| dc.date.issued | 2020 | |
| dc.date.updated | 2021-02-04T08:21:54Z | |
| dc.description.abstract | Neuropsychology as a discipline has not taken root in low- and middle-income countries. Most neurocognitive tests used in these countries were developed and normed in high-income, mostly western countries. The psychometric robustness of these tests is often weak when they are used on low to middle-income clinical populations. The objectives of this study were to select, adapt and generate normative data for a suitable neurocognitive screen for use in Zimbabwe. To achieve these objectives, we divided the study into 4 phases. In Phase 1 of the study, we did a systematic review that identified 83 neurocognitive assessment instruments commonly used in low- and middle-income countries on patients who have suffered a stroke. From these instruments, we selected, adapted and normed the Birmingham Cognitive Screen (BCoS; Humphreys al., 2012) through phases 2 to 4 of this study. The screen offers a robust and sufficiently broad but shallow assessment tool for cognitive deficits across key cognitive domains commonly impaired following a stroke. In particular, in Phase 2 of the study, we evaluated the cross-cultural sensitivity of BCoS on healthy participants (N=105). We then performed surveys using the Delphi method on a panel of experts to culturally adapt BCoS for use in Zimbabwe (Zim-BCoS). We evaluated the inter-rater and test-retest reliability of the translated and validated Zim-BCoS and also compared its agreement with the original BCoS version to determine its robustness. In Phase 3, we evaluated the effects of demographic variables on performance on the cognitive domains assessed by Zim-BCoS. To do this, we performed multiple linear regression analyses to calculate regression-based norms using scores from a sample of healthy participants (N=412). From these analyses, participants' age, level of education and sex had significant effects, mainly on subtests in the language cognitive domain (Picture Naming, Sentence/Word Reading/Writing and Instruction Comprehension). In Phase 4 of the study, we performed neurocognitive assessments using Zim-BCoS (and other tests) to assess and determine the frequency of specific neurocognitive deficits in patients who had suffered a stroke and were attending two major hospitals in Harare, Zimbabwe's capital city (N=103). We also compared the performance of these patients to a matched control sample (N=103). To determine the psychometric stability of Zim-BCoS we determined its validity and reliability by comparing scores on its subtests to parallel neurocognitive tests that assess similar cognitive domains. We also assessed the predictive value of Zim-BCoS on patients' neuropsychiatric and functional outcomes. We evaluated the convergence and predictive validity as well as the inclusivity of Zim-BCoS to assess patients with aphasia. We used the Zim-BCoS test scores to establish prevalence rates of cognitive deficits and other post-stroke sequelae in the sample of patients with stroke. We also assessed the predictive value of ZimBCoS subtests on patients' neuropsychiatric and functional outcomes. All comparisons of ZimBCoS against standard cognitive tests and post-stroke sequelae measures had statistically significant convergence, predictive validity and inclusivity. In this study, we demonstrated the utility of Zim-BCoS for assessing cognitive impairment in patients who have suffered a stroke, particularly in resource poor contexts typical of low-income countries. We concluded that ZimBCoS is a robust neuropsychological screen suitable for research and clinical use in Zimbabwe. The screen has the potential to offer a cost effective and easy to use neurocognitive screen for patients with acquired neurological changes in low-income countries in Southern Africa. | |
| dc.identifier.apacitation | Machando, D. (2020). <i>Neurocognitive screening following acquired brain injury: an adaptation of the Birmingham Cognitive Screen for Zimbabwe (Zim-BCoS)</i>. (). ,Faculty of Humanities ,Department of Psychology. Retrieved from http://hdl.handle.net/11427/32763 | en_ZA |
| dc.identifier.chicagocitation | Machando, Debra. <i>"Neurocognitive screening following acquired brain injury: an adaptation of the Birmingham Cognitive Screen for Zimbabwe (Zim-BCoS)."</i> ., ,Faculty of Humanities ,Department of Psychology, 2020. http://hdl.handle.net/11427/32763 | en_ZA |
| dc.identifier.citation | Machando, D. 2020. Neurocognitive screening following acquired brain injury: an adaptation of the Birmingham Cognitive Screen for Zimbabwe (Zim-BCoS). . ,Faculty of Humanities ,Department of Psychology. http://hdl.handle.net/11427/32763 | en_ZA |
| dc.identifier.ris | TY - Doctoral Thesis AU - Machando, Debra AB - Neuropsychology as a discipline has not taken root in low- and middle-income countries. Most neurocognitive tests used in these countries were developed and normed in high-income, mostly western countries. The psychometric robustness of these tests is often weak when they are used on low to middle-income clinical populations. The objectives of this study were to select, adapt and generate normative data for a suitable neurocognitive screen for use in Zimbabwe. To achieve these objectives, we divided the study into 4 phases. In Phase 1 of the study, we did a systematic review that identified 83 neurocognitive assessment instruments commonly used in low- and middle-income countries on patients who have suffered a stroke. From these instruments, we selected, adapted and normed the Birmingham Cognitive Screen (BCoS; Humphreys al., 2012) through phases 2 to 4 of this study. The screen offers a robust and sufficiently broad but shallow assessment tool for cognitive deficits across key cognitive domains commonly impaired following a stroke. In particular, in Phase 2 of the study, we evaluated the cross-cultural sensitivity of BCoS on healthy participants (N=105). We then performed surveys using the Delphi method on a panel of experts to culturally adapt BCoS for use in Zimbabwe (Zim-BCoS). We evaluated the inter-rater and test-retest reliability of the translated and validated Zim-BCoS and also compared its agreement with the original BCoS version to determine its robustness. In Phase 3, we evaluated the effects of demographic variables on performance on the cognitive domains assessed by Zim-BCoS. To do this, we performed multiple linear regression analyses to calculate regression-based norms using scores from a sample of healthy participants (N=412). From these analyses, participants' age, level of education and sex had significant effects, mainly on subtests in the language cognitive domain (Picture Naming, Sentence/Word Reading/Writing and Instruction Comprehension). In Phase 4 of the study, we performed neurocognitive assessments using Zim-BCoS (and other tests) to assess and determine the frequency of specific neurocognitive deficits in patients who had suffered a stroke and were attending two major hospitals in Harare, Zimbabwe's capital city (N=103). We also compared the performance of these patients to a matched control sample (N=103). To determine the psychometric stability of Zim-BCoS we determined its validity and reliability by comparing scores on its subtests to parallel neurocognitive tests that assess similar cognitive domains. We also assessed the predictive value of Zim-BCoS on patients' neuropsychiatric and functional outcomes. We evaluated the convergence and predictive validity as well as the inclusivity of Zim-BCoS to assess patients with aphasia. We used the Zim-BCoS test scores to establish prevalence rates of cognitive deficits and other post-stroke sequelae in the sample of patients with stroke. We also assessed the predictive value of ZimBCoS subtests on patients' neuropsychiatric and functional outcomes. All comparisons of ZimBCoS against standard cognitive tests and post-stroke sequelae measures had statistically significant convergence, predictive validity and inclusivity. In this study, we demonstrated the utility of Zim-BCoS for assessing cognitive impairment in patients who have suffered a stroke, particularly in resource poor contexts typical of low-income countries. We concluded that ZimBCoS is a robust neuropsychological screen suitable for research and clinical use in Zimbabwe. The screen has the potential to offer a cost effective and easy to use neurocognitive screen for patients with acquired neurological changes in low-income countries in Southern Africa. DA - 2020_ DB - OpenUCT DP - University of Cape Town KW - Psychology LK - https://open.uct.ac.za PY - 2020 T1 - Neurocognitive screening following acquired brain injury: an adaptation of the Birmingham Cognitive Screen for Zimbabwe (Zim-BCoS) TI - Neurocognitive screening following acquired brain injury: an adaptation of the Birmingham Cognitive Screen for Zimbabwe (Zim-BCoS) UR - http://hdl.handle.net/11427/32763 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/32763 | |
| dc.identifier.vancouvercitation | Machando D. Neurocognitive screening following acquired brain injury: an adaptation of the Birmingham Cognitive Screen for Zimbabwe (Zim-BCoS). []. ,Faculty of Humanities ,Department of Psychology, 2020 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/32763 | en_ZA |
| dc.language.rfc3066 | eng | |
| dc.publisher.department | Department of Psychology | |
| dc.publisher.faculty | Faculty of Humanities | |
| dc.subject | Psychology | |
| dc.title | Neurocognitive screening following acquired brain injury: an adaptation of the Birmingham Cognitive Screen for Zimbabwe (Zim-BCoS) | |
| dc.type | Doctoral Thesis | |
| dc.type.qualificationlevel | Doctoral | |
| dc.type.qualificationlevel | PhD |